You are here: Industry Insights > immunotherapy

News List

Combination immunotherapy shows promise in castration-resistant prostate cancer pharmafile
March 14, 2017
Researchers at the University of Texas MD Anderson Cancer Center have found that castration-resistant prostate cancer responds well to a combination treatment comprised of immune checkpoint blockades and myeloid-derived suppressor cell (MDSC)-targeting th
NICE rejects MSD’s Keytruda in first-line setting pharmatimes
March 02, 2017
Patients with lung cancer are unlikely to get routine NHS access to MSD's immunotherapy Keytruda in England ...
Novel ‘barcode’ tracking of T cells in immunotherapy patients identifies likely cancer-killers firstwordpharma
February 28, 2017
Fred Hutch scientists link improved treatment responses with offspring of rare T cells
Immunotherapy Not a Quick Fix for Hay Fever drugs.com
February 15, 2017
Immunotherapy -- often in the form of allergy shots -- can combat the runny nose, itchy eyes, congestion, sneezing and sinus pressure of persistent hay fever.
ViraCyte Receives Orphan Drug Designation for Viralym-C firstwordpharma
January 25, 2017
ViraCyte, LLC announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation to Viralym-C, a ready to administer T cell immunotherapy product for the treatment of cytomegalovirus (CMV) in severely immunocompromised pa
Amgen, Immatics ink deal potentially worth over $1 billion to develop cancer immunotherapies firstwordpharma
January 10, 2017
Amgen and Immatics Biotechnologies on Monday announced an agreement potentially worth more than $1 billion to jointly develop next-generation T-cell engaging bispecific immunotherapies targeting multiple cancers
Bristol-Myers Squibb announces immunotherapy clinical collaboration with Janssen worldpharmanews
January 06, 2017
Bristol-Myers Squibb Company (NYSE:BMY) today announced a new clinical research collaboration with Janssen Biotech, Inc.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page